Home » TARO PHARMACEUTICAL GETS TENTATIVE ANDA OK FOR TWO DRUGS
TARO PHARMACEUTICAL GETS TENTATIVE ANDA OK FOR TWO DRUGS
Taro Pharmaceuticals Industries Inc. (TARO) said Monday it received tentative
approval from the U.S. Food and Drug Administration for its abbreviated new
drug applications for carvedilol tablets and for ondansetron hydrochloride tablets.
Therapeutics
Daily
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct